Business Wire

MAXON

7.9.2022 17:01:36 CEST | Business Wire | Press release

Share
Maxon One Fall Update Brings Advanced Simulation, Overall Enhancements and Optimized Workflows

Maxon, developers of professional software solutions for editors, filmmakers, motion designers and visual effects artists, today announced a host of updates to the company’s product line. With this major Fall 2022 update, Maxon One receives a wide range of new features and enhancements. Cinema 4D 2023 introduces some of the most requested features - including dramatic simulation advancements, modeling with symmetry, improved asset management and native OCIO support. The Redshift team continues its breakneck development pace by adding Stacked Materials. Forger now supports entirely new professional workflows with the addition of Cinema 4D's polygonal modeling engine. Red Giant added text effects for Universe, new sprites for Trapcode and performance updates for VFX. Moves by Maxon gets a facelift and improved workflow. And Maxon continues to add value to its Capsules initiative with new assets for Cinema 4D.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220907005806/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Maxon One Receives Major Fall 2022 Update With a Wide Range of New Features and Enhancements. Image courtesy of Vladislav Solovjov

Cinema 4D 2023 introduces new features, including Symmetry modeling, enhancements to the Unified Simulation System, Vertex Maps and Vertex Color tags Fields control on most generators and support for OpenColorIO so artists can take full advantage of cinematic ACEScg color space and a unified color pipeline across all Maxon tools. Additionally, C4D 2023 includes an improved GoZ bridge for easy transfer of models between C4D and ZBrush. Finally, a new collection of coffee table Capsules optimized with Redshift materials has been added.

Redshift: On top of the recent advancements - Rounded Corners, Random Walk and major developments to volume technology, the latest version now includes Material Stacking for decals, material blending and texture remapping.

Forger now includes Cinema 4D's powerful, Polygonal Modeling Tools for extruding points, edges or polygons, beveling edges and more – right inside of Forger. An on-screen 3D Gizmo supplies useful actions such as moving along an axis, rotation, scaling and transforming. And, artists can move models between Forger and Cinema 4D easily using the new Sharing feature.

Red Giant 2023

  • Trapcode now includes over 75 new animated sprites for 2D shapes and bursts. And, the loading time for the Particular Designer has been dramatically improved.
  • Magic Bullet adds the recently released Halation and Diffusion tools to Looks in Cinema 4D and an improved Looks C4D workflow in OCIO mode. There have been major improvements to the Looks integration in Unreal Engine 5. Finally, Denoiser is now available for Final Cut Pro and compatible with Apple M1 machines.
  • VFX offers enhanced performance and stability, and many performance enhancements for Supercomp, Primatte, Real Lens Flares and more.
  • Universe has added support for alpha layers in Avid Media Composer, the ability to generate text effects, track mattes and more, and over 100 new presets for Generators.

Moves by Maxon with a new look and updates to capture workflows and stability, it’s now even easier to capture face and body movements.

About Maxon

Maxon makes powerful, yet approachable software solutions for content creators working in 2D and 3D design, motion graphics, visual effects and visualization. Maxon’s innovative product portfolio helps artists supercharge their creative workflows. Our product lines include the award-winning Cinema 4D suite of 3D modeling, simulation and animation technology; the creativity-on-the-go Forger mobile sculpting app; the diverse Red Giant lineup of revolutionary editing, motion design and filmmaking tools; the leading-edge, blazingly fast Redshift renderer; and ZBrush, the industry-standard digital sculpting and painting solution.

Maxon’s team is comprised of fun, passionate people who believe in building and empowering a successful artistic community. From our popular, inclusive events to our free Cineversity educational resources, Maxon recognizes that developing strong connections with creatives and fostering their professional growth is integral to our ability to stay on top of industry trends and better serve customers.

Maxon is part of the Nemetschek Group.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220907005806/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations30.4.2026 14:05:00 CEST | Press release

Significant unmet need remains for 85% of lupus patients whose disease includes skin manifestations, often associated with substantial physical and psychosocial burdenEnpatoran, an oral TLR7/8 inhibitor, is designed for lupus patients with active cutaneous manifestations, with the goal of broadening the treatment paradigm beyond the current standardsELOWEN is a global Phase 3 program evaluating enpatoran’s impact on both skin and systemic symptoms in patients with lupus and potential links between skin and systemic disease activity Merck, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ELOWEN-1 (NCT07332481) and ELOWEN-2 (NCT07355218), evaluating enpatoran in people living with lupus who experience active skin manifestations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430733656/en/ David Weinreich, Global Head of R&D and Chief Medical Officer “People

Riskified Announces 2026 Titans of Ecommerce Award Winners30.4.2026 14:00:00 CEST | Press release

Celebrating the ecommerce leaders from Michael Kors and Gymshark shaping the future of fraud prevention and risk management Riskified (NYSE: RSKD), a global leader in ecommerce fraud and risk intelligence, today announced the 2026 Titans of Ecommerce Awards, recognizing outstanding ecommerce leaders who are redefining fraud prevention while driving business growth. The winners are:Titan of Americas: Joseph Chin, Senior Director of Revenue Assurance, Michael Kors Joseph Chin has evolved revenue assurance into a strategic lever for growth at Michael Kors. Deeply knowledgeable in fraud and payments, he maintains a hands-on approach, continually collaborating with Riskified to identify innovative opportunities, optimize performance, and pilot new initiatives. Joseph is highly effective at building internal alignment and securing stakeholder buy-in for new strategies. His leadership shone during Cyber Five, where his close collaboration with Riskified and real-time insights delivered one of

The LYCRA Company Strengthens Sustainability Leadership, Appoints Alistair Williamson as VP of Product Sustainability30.4.2026 14:00:00 CEST | Press release

The LYCRA Company has appointed longtime executive Alistair Williamson as vice president of product sustainability, reaffirming its commitment to developing sustainable solutions for apparel and personal care products. In this role, he will guide the company’s next chapter of sustainability strategy and oversee all initiatives aimed at reducing environmental impact across products, operations, and innovation platforms. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430942396/en/ The LYCRA Company has appointed longtime executive Alistair Williamson as vice president of product sustainability, reaffirming its commitment to developing sustainable solutions for apparel and personal care products. Williamson has four decades of experience in textile fibers and apparel, having held commercial, sales, and marketing leadership roles across EMEA, North America, and South Asia. Before joining the predecessor of The LYCRA Company i

CorFlow Therapeutics Announces Successful Completion of Phase 1 and First Patients Enrolled in Phase 2 of the MOCA II Pivotal Trial, Approval to Start the REVITALISE RCT in Europe, and Strengthening of Clinical Leadership30.4.2026 13:00:00 CEST | Press release

Milestones advance clinical progress and path to commercialization CorFlow Therapeutics AG (CorFlow), a clinical-stage company focused on transforming the diagnosis and treatment for heart attack patients, today announced multiple milestones in advancing its clinical program and the strengthening of clinical leadership. Phase 1 of the company’s MOCA II FDA Pivotal Trial was successfully reached after safety and performance goals were met with STEMI heart attack patients who had the proprietary PCoFI diagnostic measurement of microvascular obstruction (MVO) made during a stenting procedure, when compared to the reference standard diagnosis by cardiac MRI in the subsequent days. Phase 1 included 19 patients enrolled across 5 US and 3 European sites. MOCA II follows the FIH MOCA I study and primarily aims to validate the threshold value of the proprietary PCoFI measurement for diagnosing MVO in the setting of primary angioplasty compared to cardiac MRI. This milestone achievement, which w

Agendia to Present New Data Demonstrating the Expanded Clinical Utility of MammaPrint® and BluePrint® at the 2026 ESMO Breast Cancer Annual Congress30.4.2026 13:00:00 CEST | Press release

Poster presentations highlight the prognostic value of MammaPrint + Blueprint in small, node-negative tumors and impact of BMI on recurrence dynamics Agendia®, Inc., a leader in precision oncology for breast cancer, today announced it will present new data at the 2026 European Society for Medical Oncology (ESMO) Annual Congress on Breast Cancer, taking place May 6-8 in Berlin, Germany. The company will present two posters featuring data from the prospective FLEX Study and an independent post hoc analysis of the landmark MINDACT trial that underscore the prognostic value of MammaPrint® + BluePrint® in early-stage breast cancer (EBC). Poster #65P | Thursday, May 7, 13:15 – 14:15 p.m. CEST | Presenter: Elena Shagisultanova Prognostic Performance of MammaPrint in Patients with Small T1a, b, and c Node-Negative Early Breast Cancer A retrospective analysis from the FLEX Study involving 4,349 patients highlights the biological heterogeneity within small, node-negative (T1a, b, and c) tumors –

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye